These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17350460)

  • 21. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
    Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
    Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
    Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
    DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of 1p35-36 genes in neuroblastoma.
    Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
    Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
    Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
    Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter.
    Muñoz J; Castresana JS
    Neoplasma; 2006; 53(1):15-8. PubMed ID: 16416007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LOH at chromosome 9q34.3 and the Notch1 gene methylation are less involved in oral squamous cell carcinomas.
    Gao S; Krogdahl A; Eiberg H; Liu CJ; Sørensen JA
    J Oral Pathol Med; 2007 Mar; 36(3):173-6. PubMed ID: 17305639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers.
    Kawakami K; Yasuda J; Shiraishi M; Kayama T; Doi K; Perucho M; Sekiya T
    Biochem Biophys Res Commun; 1998 Oct; 251(1):153-7. PubMed ID: 9790923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
    Maris JM; Guo C; White PS; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):24-7. PubMed ID: 11464895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
    White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
    Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
    Wong NA; Britton MP; Choi GS; Stanton TK; Bicknell DC; Wilding JL; Bodmer WF
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):574-9. PubMed ID: 14704280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.
    Muñoz J; Lázcoz P; Inda MM; Nistal M; Pestaña A; Encío IJ; Castresana JS
    Int J Cancer; 2004 May; 109(5):673-9. PubMed ID: 14999773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter hypermethylation in biliary tract carcinoma.
    Kohya N; Koga Y; Kitajima Y; Miyazaki K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.